PHARMA STOCKS
Oriental Carbon shares surge 9% as BofA buys stake in Rs 300-crore microcap firm
Oriental Carbon & Chemicals shares saw a rise. This happened after Bank of America purchased shares via a block deal. The deal involved 53,428 shares at Rs 289.53 each. The total deal value reached approximately Rs 1.5 crore. The company's stock is currently showing low volatility. However, analysts suggest a potential downside based on target prices.
CreditAccess Grameen shares rally over 4% after securing $100 million syndicated loan from Asian banks
CreditAccess Grameen has secured a $100 million syndicated loan from a consortium of Asian banks, led by Standard Chartered. The dual-currency facility—denominated in yen and dollars—will support eligible social projects. The microfinance-focused NBFC had initially launched the loan at $70 million in November 2024 before upsizing it due to strong demand.
Ahead of Market: 10 things that will decide stock market action on Wednesday
Sensex slipped 53.49 points and Nifty remained flat on Tuesday as profit booking in financials offset optimism from U.S.-China talks and RBI support, with selective buying in IT and pharma.
Stock market update: Nifty Pharma index advances 0.56%
The Nifty Pharma index closed 0.56 per cent up at 21948.0.
Deven Choksey on 3 insurance stocks to invest in now
Deven Choksey, MD of DRChoksey FinServ, says private sector insurance companies are relatively more favourable from a growth perspective. Valuation-wise, some of them have already started scaling up. There is good potential in the likes of SBI and HDFC Life and also Bajaj Life Insurance business. He likes those businesses from an investment perspective.
Stock market update: Nifty Pharma index advances 0.19% in an upbeat market
The Nifty Pharma index was trading 0.19 per cent up at 21867.65.
- Go To Page 1
Stock market update: Nifty Pharma index advances 0.66%
The Nifty Pharma index closed 0.66 per cent up at 21826.8.
Stock market update: Nifty Pharma index advances 0.3% in an upbeat market
The Nifty Pharma index was trading 0.3 per cent up at 21748.9.
3 equity mutual fund categories lose up to 7% in 2025. Expert shares what went wrong
Equity mutual funds face losses this year. Technology, pharma, and small-cap funds are the top losers. Tata Digital India Fund saw the biggest drop. Experts cite global tech slowdown and valuation concerns. Small-cap funds suffer from muted earnings. Investors should consider staggered investments. Pharma shows improved entry points. A SIP-based approach is advisable for small caps.
Stock Radar: P&G Health stock gave a breakout from falling trendline on weekly charts; check target & stop loss
Procter & Gamble Health Ltd. has broken out from a falling trendline, reaching a new 52-week high, signaling potential for further gains. Experts suggest short-term traders consider buying, targeting Rs 6,700 within 2-3 months. Supported by strong momentum and positive technical indicators, the stock's uptrend is expected to continue, with a crucial support level established around Rs 5,000.
Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 28% in 1 year
While the bulls were clearly making a comeback, the RBI’s move to cut both the repo rate and CRR has just helped them some more. Now, there are two schools of thought on the RBI move. One says a cut in interest rate suggests the economy is slowing and requires a push. The other says that boosting liquidity and giving cash in people’s hands, when done in time, aids a faster recovery. Whatever be the case, the one thing to keep an eye on is inflation. Our selected stocks for today depict a strong upward trajectory in their overall average score which is based on five key pillars: Earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
HDFC Life, BEL, Bharti Airtel, Tata Steel and Sun Pharma were among the top losers on NSE in today's trade.
Stock market update: Nifty Pharma index advances 0.19%
The Nifty Pharma index closed 0.19 per cent up at 21684.4.
Underweight on US since January; overweight on Europe, China & India: Devina Mehra
Devina Mehra of First Global suggests remaining invested in Indian markets. They are underweight in the US since January. They favor Europe and maintain overweight positions in China and India. Recent rebalancing in India includes overweighting pharma and auto components since early 2024. FMCG and banks have seen increased weight. However, banks remain underweight despite recent additions.
Stock market update: Stocks that hit 52-week lows on NSE
Tata Steel, BEL, Sun Pharma, Infosys and Nestle India were among the top losers on NSE.
Stock market update: Nifty Pharma index falls 0.21% in an upbeat market
The Nifty Pharma index was trading 0.21 per cent down at 21599.7.
Stock market update: Stocks that hit 52-week highs on NSE
Indef Manufacturing, Peria Karamalai Tea, Manaksia Coated, Reliance Home Fin and Federal Mogul, hit their fresh 52-week highs at 10:25AM.
Stock market update: Nifty Pharma index advances 1.28%
The Nifty Pharma index closed 1.28 per cent up at 21644.2.
Stock Radar: Strides Pharma breaks out from 7-month consolidation to hit fresh 52-week high; time to buy?
Strides Pharma Science stock shows positive movement. It broke a seven-month consolidation phase. Experts suggest a buy with a target of Rs 960 in 1-2 months. The stock demonstrated strong momentum, breaking resistance at Rs 760. Technical indicators support a bullish outlook. A stop loss is advised at Rs 750 for risk management. Market participation has increased.
Stock market update: Nifty Pharma index advances 1.03% in an upbeat market
The Nifty Pharma index was trading 1.03 per cent up at 21591.95.
Gland Pharma shares in focus after subsidiary Cenexi gets 11 observations from French regulator
Gland Pharma shares will be in focus after its subsidiary Cenexi received 11 observations from France’s ANSM following a GMP inspection at its Fontenay facility. The company clarified that operations remain unaffected and a CAPA plan has been accepted. Gland Pharma shares have risen 16% in a month, though the stock is still down 43% over three years.
Stocks in news: Vedanta, Gland Pharma, YES Bank, Power Grid, BEL
Markets experienced range-bound trading, closing slightly higher after Tuesday's dip. Vedanta Resources explores refinancing a $550 million credit facility, while Gland Pharma's Cenexi received observations from France's drug regulator. CA Basque Investments reduced its stake in YES Bank, and Power Grid acquired MEL Power Transmission Ltd. REC plans to raise funds, and BEL secured new orders worth Rs 537 crore.
Stock market update: Nifty Pharma index advances 0.08%
The Nifty Pharma index closed 0.08 per cent up at 21371.7.
Sensex rises! These stocks gained over 10% on BSE
In the Nifty 50 index, 32 stocks ended in the green, while 18 stocks closed in the red in today's trade.
Sensex rises! But these stocks are down 5% or more on BSE
In the Nifty pack, 30 stocks were trading in the green, while 20 stocks were trading in the red.
Stock market update: Nifty Pharma index advances 0.05% in an upbeat market
The Nifty Pharma index was trading 0.05 per cent up at 21364.0.
Stock market update: Stocks that hit 52-week lows on NSE
Trent, Sun Pharma, ONGC, NTPC and TCS were among the top losers on NSE.
Stock market update: Nifty Pharma index falls 0.06% in a weak market
The Nifty Pharma index was trading 0.06 per cent down at 21381.3.
Load More
